|
1
|
Andersen TL, Sondergaard TE, Skorzynska
KE, et al: A physical mechanism for coupling bone resorption and
formation in adult human bone. Am J Pathol. 174:239–247. 2009.
View Article : Google Scholar :
|
|
2
|
Trouvin AP and Goëb V: Receptor activator
of nuclear factor-κB ligand and osteoprotegrin: maintaining the
balance to prevent bone loss. Clin Interv Aging. 5:345–354.
2010.
|
|
3
|
Dougall WC: Molecular pathways:
osteoclast-dependent and osteoclast-independent roles of the
RANKL/RANK/OPG pathway in tumorigenesis and metastasis. Clin Cancer
Res. 18:326–335. 2012. View Article : Google Scholar
|
|
4
|
Raju R, Balakrishnan L, Nanjappa V, et al:
A comprehensive manually curated reaction map of
RANKL/RANK-signalling pathway. Database (Oxford). 2011:bar0212011.
View Article : Google Scholar
|
|
5
|
Singh PP, van der Kraan AG, Xu J,
Gillespie MT and Quinn JM: Membrane-bound receptor activator of
NFκB ligand (RANKL) activity displayed by osteoblasts is
differentially regulated by osteolytic factors. Biochem Biophys Res
Commun. 422:48–53. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rachner TD, Khosla S and Hofbauer LC:
Osteoporosis: now and the future. Lancet. 377:1276–1287. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu WT, Lee RP, Wang CH, et al: The
association of serum osteoprotegerin and osteoporosis in
postmenopausal hemodialysis patients: a pilot study. J Womens
Health (Larchmt). 19:785–790. 2010. View Article : Google Scholar
|
|
8
|
Reitmanova S and Gustafson DL: Coloring
the white plague: a syndemic approach to immigrant tuberculosis in
Canada. Ethn Health. 17:403–418. 2012. View Article : Google Scholar
|
|
9
|
Glaziou P, Falzon D, Floyd K and
Raviglione M: Global epidemiology of tuberculosis. Semin Respir
Crit Care Med. 34:3–16. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Corrado A, Neve A, Macchiarola A, et al:
RANKL/OPG ratio and DKK-1 expression in primary osteoblastic
cultures from osteoarthritic and osteoporotic subjects. J
Rheumatol. 40:684–694. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Henderson B, Lund PA and Coates AR:
Multiple moonlighting functions of mycobacterial molecular
chaperons. Tuberculosis (Edinb). 90:119–124. 2010. View Article : Google Scholar
|
|
12
|
Taneja B and Mande SC: Metal ions modulate
the plastic nature of Mycobacterium tuberculosis chaperonin-10.
Protein Eng. 14:391–395. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meghji S, White PA, Nair SP, et al:
Mycobacterium tuberculosis chaperonin 10 stimulates bone
resorption: a potential contributory factor in Pott’s disease. J
Exp Med. 186:1241–1246. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jonsson KB, Frost A, Nilsson O, Ljunghall
S and Ljunggren O: Three isolation techniques for primary culture
of human osteoblastlike cells: a comparison. Acta Orthop Scand.
70:365–373. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brändström H, Björkman T and Ljunggren O:
Regulation of osteoprotegerin secretion from primary cultures of
human bone marrow stromal cells. Biochem Biophys Res Commun.
280:831–835. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suda T, Takahashi N, Udagawa N, et al:
Modulation of osteoclast differentiation and function by the new
members of the tumor necrosis factor receptor and ligand families.
Endocr Rev. 20:345–357. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Morony S, Tintut Y, Zhang Z, et al:
Osteoprotegerin inhibits vascular calcification without affecting
atherosclerosis in ldlr(−/−) mice. Circulation. 117:411–420. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jones DH, Nakashima T, Sanchez OH, et al:
Regulation of cancer cell migration and bone metastasis by RANKL.
Nature. 440:692–696. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Yang C, Xie WL, et al: Puerarin
concurrently stimulates osteoprotegerin and inhibits receptor
activator of NF-κB ligand (RANKL) and interleukin-6 production in
human osteoblastic MG-63 cells. Phytomedicine. 21:1032–1036. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiong Q, Zhang LC, Zhang LH, et al:
Effects of recombinant human osteoprotegerin and recombinant RANK
protein on the differentiation of osteoclast precursors. Zhongguo
Gu Shang. 26:324–327. 2013.PubMed/NCBI
|
|
21
|
Goranova-Marinova V, Goranov S, Pavlov P
and Tzvetkova T: Serum levels of OPG, RANKL and RANKL/OPG ratio in
newly-diagnosed patients with multiple myeloma. Clinical
correlations. Haematologica. 92:1000–1001. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Samelson EJ, Broe KE, Demissie S, et al:
Increased plasma osteoprotegerin concentrations are associated with
indices of bone strength of the hip. J Clin Endocrinol Metab.
93:1789–1795. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kearns AE, Khosla S and Kostenuik PJ:
Receptor activator of nuclear factor kappaB ligand and
osteoprotegerin regulation of bone remodeling in health and
disease. Endocr Rev. 29:155–192. 2008. View Article : Google Scholar
|
|
24
|
Lamoureux F, Richard P, Wittrant Y, et al:
Therapeutic relevance of osteoprotegerin gene therapy in
osteosarcoma: blockade of the vicious cycle between tumor cell
proliferation and bone resorption. Cancer Res. 167:7308–7318. 2007.
View Article : Google Scholar
|
|
25
|
Joseph F, Chan BY, Durham BH, et al: The
circadian rhythm of osteoprotegerin and its association with
parathyroid hormone secretion. J Clin Endocrinol Metab.
92:3230–3238. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Roberts MM, Coker AR, Fossati G, et al:
Mycobacerium tuberculosis chaperonin 10 heptamers self-associate
through their biologically active loops. J Bacteriol.
185:4172–4185. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qamra R, Mande SC, Coates AR and Henderson
B: The unusual chaperonins of Mycobacterium tuberculosis.
Tuberculosis (Edinb). 85:385–394. 2005. View Article : Google Scholar
|
|
28
|
Roberts MM, Coker AR, Fossati G, et al:
Mycobacterium tuberculosis chaperonin 10 heptamers self-associate
through their biologically active loops. J Bacteriol.
185:4172–4185. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Castanié-Cornet MP, Bruel N and Genevaux
P: Chaperone networking facilitates protein targeting to the
bacterial cytoplasmic membrane. Biochim Biophys Acta.
1843:1442–1456. 2014. View Article : Google Scholar
|
|
30
|
Henderson B, Lund PA and Coates AR:
Multiple moonlighting functions of mycobacterial molecular
chaperones. Tuberculosis (Edinb). 90:119–124. 2010. View Article : Google Scholar
|
|
31
|
Bai YD, Yang FS, Xuan K, Bai YX and Wu BL:
Inhibition of RANK/RANKL signal transduction pathway: a promising
approach for osteoporosis treatment. Med Hypotheses. 71:256–258.
2008. View Article : Google Scholar : PubMed/NCBI
|
